Alvotech (NASDAQ:ALVOW – Get Free Report) was the target of a significant decrease in short interest in the month of January. As of January 15th, there was short interest totaling 1,076 shares, a decrease of 30.7% from the December 31st total of 1,552 shares. Based on an average daily volume of 698 shares, the days-to-cover ratio is currently 1.5 days. Based on an average daily volume of 698 shares, the days-to-cover ratio is currently 1.5 days.
Alvotech Stock Down 6.5%
Shares of ALVOW opened at $0.43 on Friday. The company has a 50 day simple moving average of $0.65 and a two-hundred day simple moving average of $1.10. Alvotech has a 1 year low of $0.41 and a 1 year high of $3.00.
Alvotech Company Profile
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Recommended Stories
- Five stocks we like better than Alvotech
- Stock market legend warns: “An Ominous Day Is Coming for the Markets…”
- Another reason you need to own gold… [running out]
- Trump’s Final Shocking Act Begins February 24
- NEW: Gold makes history
- Deutsche Bank Just Raised Their Gold Target to $6,000
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
